- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05703906
Teleneurorehabilitation for the Continuity of Care Post-stroke: a Multicentric Pilot Study (TELEICTUS)
January 19, 2023 updated by: IRCCS San Camillo, Venezia, Italy
The main aim of this longitudinal, pilot study is to evaluate the feasibility of a multi-domain (i.e., motor, language and cognitive domains) telerehabilitation system using the Virtual Reality Rehabilitation System (VRRS, Khymeia) in patients with stroke.
Furthermore, data on patients' needs and clinical data will be collected before and after treatment and then analyzed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Venice, Italy, 30126
- IRCCS San Camillo Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Single ischemic stroke documented by CT/ MRI;
- 2 to 18 months after the event.
Exclusion Criteria:
- medical history or presence of cognitive decline (MoCA<17.54)
- recent fractures
- History of mental disorders (major depression, psychosis)
- History/presence of other neurological disorders that may interfere with outcome
- Presence of other internal pathologies that may interfere with outcome or treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telerehabilitation
All patients will receive a kit home-based consisting of a tablet home, an exercise equipment and access to a daily individualized training program based on their needs (i.e., motor, language and/or cognitive training programs). The exercise program and patients' sessions will be remotely supervised by therapists. |
Participants will receive an individualized, multidomain exercise program set up by the therapist, based on their needs.
The intervention applied will consist of 20 sessions of motor, language and/or cognitive training distributed in five sessions for week, each lasting 1 hour.
Remotely, the therapist will supervise the participant's exercise program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of telerehabilitation system
Time Frame: 6 weeks
|
Feasibility will be measured by calculating the adherence to treatment (i.e. percentage of training sessions completed).
|
6 weeks
|
Feasibility of telerehabilitation system
Time Frame: 6 weeks
|
Feasibility will be measured with the Technology Acceptance Model (TAM), a specific questionnaire used to quantify the likelihood of technology acceptance, consisting of 12 items, six assessing perceived usefulness and six assessing perceived ease of use.
|
6 weeks
|
Feasibility of telerehabilitation system
Time Frame: 6 weeks
|
Feasibility will be measured with the System Usability Questionnaire (SUS), a 10 item questionnaire with five response options: from Strongly agree to Strongly disagree.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in measure of quality of life
Time Frame: Baseline up to 6 weeks
|
Quality of life will be measured by the Short-Form-36 Health Survey (SF-36), a questionnaire comprising 36 questions that cover 8 domains of health.
Each of the 8 summed scores is linearly transformed onto a scale from 0 (negative health) to 100 (positive health) to provide a score for each domain.
Each domain can be used independently.
|
Baseline up to 6 weeks
|
Change in measure of quality of life
Time Frame: Baseline up to 6 weeks
|
Quality of life will be measured by the EuroQol-5 dimensions (EQ-5D), a questionnaire measuring 5 dimensions described by 3 possible levels of problems (i.e., none, mild-to-moderate, severe).
Respondent's answers are translated into a preference-based score, yielding an index score based on a scale from 0.000 (death) to 1.000 (perfect health).
The 5 dimensions can be converted to a single utility value (EQ-Index score).
|
Baseline up to 6 weeks
|
Change in motor functions
Time Frame: Baseline up to 6 weeks
|
Change in motor functions will be assessed with the Fugl-Meyer Assessment (FMA), a stroke-specific scale which assesses the motor functioning in patients with post-stroke.
There are 3 values for each of the 5 domain: 0 (severe impairment), 1 (moderate impairment), 2 (preserved function).
The 5 domains assessed include: motor function (upper limb maximum score = 66; lower limb maximum score = 34), sensory function (maximum score = 24), balance (maximum score = 14), joint range of motion (maximum score = 44), joint pain (maximum score = 44), for an overall maximum score of 226 points.
|
Baseline up to 6 weeks
|
Change in motor functions
Time Frame: Baseline up to 6 weeks
|
Assessed with the Nine hole pegboard test (NHPT), to measure finger dexterity.
It is administered by asking the participant to take the pegs from a container, one by one, and place them into holes on the board as quickly as possible.
Scores are based on the time taken to complete the activity, recorded in seconds.
|
Baseline up to 6 weeks
|
Change in motor functions
Time Frame: Baseline up to 6 weeks
|
Assessed with the Box and block test (BBT).
The patient has to carry as much cubes as possible, one by one, from a container to another one in one minute.
The test is performed with both hands.
|
Baseline up to 6 weeks
|
Change in motor functions
Time Frame: Baseline up to 6 weeks
|
Assessed with the Ashworth Spasticity Scale.
The therapist evaluates the spasticity of the muscles.
There are 5 values: 0 (no increase in muscle tone), 1 (slight increase in muscle tone), 2 (more marked increase in muscle tone), 3 (considerable increase in muscle tone), 4 (affected part rigid in flexion or extension).
|
Baseline up to 6 weeks
|
Change in linguistic functions
Time Frame: Baseline up to 6 weeks
|
Aachen Aphasie Test (AAT)
|
Baseline up to 6 weeks
|
Change in cognitive functions
Time Frame: Baseline up to 6 weeks
|
Assessed with the Montreal Cognitive Assessment (MoCA), a cognitive screening tool comprising 16 items and 11 categories to assess multiple cognitive domains.
The total possible score is 30, corresponding to a good performance.
|
Baseline up to 6 weeks
|
Change in cognitive functions
Time Frame: Baseline up to 6 weeks
|
Assessed with the Bells test, a cancellation test that allows for a quantitative and qualitative assessment of visual neglect in the near extra personal space.
The total number of cancelled bells is recorded as well as the time taken to complete.
The maximum score is 35.
|
Baseline up to 6 weeks
|
Change in cognitive functions
Time Frame: Baseline up to 6 weeks
|
Assessed with the verbal fluency test.
Participants have to produce as many words as possible from a semantic and a phonemic category in 1 minute.
|
Baseline up to 6 weeks
|
Change in Independence (Activities of Daily Living)
Time Frame: Baseline up to 6 weeks
|
Assessed with the Barthel Index (BI).
It comprises 10 ADL/mobility activities, items are rated based on the amount of assistance required to complete each activity.
Each item score ranges from 0 (dependent) to 10 (independent).
|
Baseline up to 6 weeks
|
Change in behavior (depression)
Time Frame: Baseline up to 6 weeks
|
Assessed with the Beck Depression Inventory (BDI).
Items are on a four-point scale that ranges from 0 to 3. Ratings are summed to provide a total score ranging from 0-63.
Scores >10 generally meet the threshold for a diagnosis of depression.
|
Baseline up to 6 weeks
|
Change in caregiver burden
Time Frame: Baseline up to 6 weeks
|
Assessed with the Zarit Burden Interview (ZBI).
It comprises 22 items with a score ranging from 0 ("never" to 4 ("nearly always").
Total scores are obrained by summing all items endorsed.
|
Baseline up to 6 weeks
|
Satisfaction of the treatment
Time Frame: 6 weeks
|
Client Satisfaction Questionnaire, it consists of a 6 item questionnaire with five response options: from 0 to 4, where 0 reflects a negative response and 4 reflects a positive response.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Luisa Cacciante, MSc, IRCCS San Camillo Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cacciante L, Kiper P, Garzon M, Baldan F, Federico S, Turolla A, Agostini M. Telerehabilitation for people with aphasia: A systematic review and meta-analysis. J Commun Disord. 2021 Jul-Aug;92:106111. doi: 10.1016/j.jcomdis.2021.106111. Epub 2021 May 13.
- Cacciante L, Pieta CD, Rutkowski S, Cieslik B, Szczepanska-Gieracha J, Agostini M, Kiper P. Cognitive telerehabilitation in neurological patients: systematic review and meta-analysis. Neurol Sci. 2022 Feb;43(2):847-862. doi: 10.1007/s10072-021-05770-6. Epub 2021 Nov 25.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 16, 2018
Primary Completion (Actual)
November 30, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
December 12, 2022
First Submitted That Met QC Criteria
January 19, 2023
First Posted (Estimate)
January 30, 2023
Study Record Updates
Last Update Posted (Estimate)
January 30, 2023
Last Update Submitted That Met QC Criteria
January 19, 2023
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017.16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamActive, not recruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
University of MinnesotaAmerican Occupational Therapy FoundationActive, not recruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Telerehabilitation - VRRS Khymeia
-
IRCCS Eugenio MedeaRecruitingNeurological Diseases or ConditionsItaly
-
Fondazione Don Carlo Gnocchi OnlusIRCCS San Camillo, Venezia, Italy; Istituti Clinici Scientifici Maugeri SpA; IRCCS... and other collaboratorsActive, not recruiting
-
IRCCS San Raffaele RomaCompletedTotal Knee Replacement | Knee ArthropathyItaly
-
IRCCS Fondazione Stella MarisFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione I.R... and other collaboratorsRecruitingNeurodevelopmental Cognitive, Motor and Speech-language DisabilitiesItaly
-
IRCCS Centro San Giovanni di Dio FatebenefratelliIRCCS San Raffaele; Fondazione Don Carlo Gnocchi Onlus; IRCCS Centro Neurolesi...Active, not recruiting
-
IRCCS San Raffaele RomaRecruiting
-
IRCCS Eugenio MedeaRecruitingMuscular Dystrophies | Becker Muscular Dystrophy | Limb Girdle Muscular Dystrophy | Facio-Scapulo-Humeral DystrophyItaly
-
IRCCS San Raffaele RomaIRCCS San Camillo, Venezia, Italy; IRCCS Centro Neurolesi "Bonino-Pulejo"; Fondazione... and other collaboratorsCompleted
-
IRCCS Centro Neurolesi "Bonino-Pulejo"Enrolling by invitationIntellectual Disability | Autism Spectrum DisorderItaly
-
Giovanni CioniAzienda USL Toscana Nord Ovest; Scuola Superiore Sant'Anna di PisaRecruitingCongenital and Acquired Developmental DisabilitiesItaly